Treatment of conjunctival palpebral lesions using ruthenium plaque brachytherapy "Sandwich Technique".


Journal

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
ISSN: 1715-3360
Titre abrégé: Can J Ophthalmol
Pays: England
ID NLM: 0045312

Informations de publication

Date de publication:
03 Aug 2024
Historique:
received: 16 02 2024
revised: 12 06 2024
accepted: 02 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 6 8 2024
Statut: aheadofprint

Résumé

Treatment of palpebral conjunctival lesions is problematic due to late diagnosis, difficult surgical approach, and the need to preserve eyelid integrity. We describe our treatment experience using plaque brachytherapy in the "sandwich technique." A retrospective study. We reviewed the medical records of patients treated by plaque brachytherapy for conjunctival lesions at the Hadassah Medical Center between January 1, 2013, and January 1, 2024, and included in the analysis patients treated for palpebral conjunctival lesions. Ruthenium plaque was sutured to the palpebral conjunctiva. The matching nonradioactive "dummy" plaque was sutured to the external eyelid to flip the tarsal's curvature. The study cohort included 5 patients, 2 men (40%) and 3 women (60%) at a median age of 68.11 years (range: 47-79.7 years). Three patients had conjunctival melanoma (60%), 1 had sebaceous carcinoma (20%), and 1 had extensive carcinoma in situ (20%). All lesions were in the left upper eyelid. Median follow-up was 37.6 months (range: 18.7-110.6 months). Four patients demonstrated a complete response (80%), while one had a partial response (20%). There was local recurrence in 1 patient (20%), and 1 patient had new foci elsewhere (20%). All patients had full local control after adding local treatments. One patient developed metastatic disease and died (20%). All patients had manageable madarosis and conjunctival scars. Treatment of palpebral conjunctival lesions using "sandwich" plaque brachytherapy is safe and effective. To the best of our knowledge, this treatment was never described before, and we believe it should be added to our armamentarium.

Identifiants

pubmed: 39106964
pii: S0008-4182(24)00213-8
doi: 10.1016/j.jcjo.2024.07.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Shahar Frenkel (S)

Division of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: shahar.frenkel@gmail.com.

Jacob Pe'er (J)

Division of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.

Yael Deckel (Y)

Division of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.

Zvi Gur (Z)

Division of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.

Shay Ofir (S)

Division of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.

Maya Eiger-Moscovich (M)

Division of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.

Classifications MeSH